The Italian Competition Authority decides that commitments submitted by pharmaceutical companies in order to alleviate competition concerns should have been published (Arca / Novartis-Italfarmaco)

The Italian Competition Authority (AGCM) decided that, according to Art. 14-ter of Italian Law 287/1990, the commitments that Novartis and Italfarmaco had submitted in order to alleviate concerns in terms of an alleged infringement of Art. 101 TFEU, should have been published, both in its journal and on its website, on 29 December 2014. Third parties interested in submitting observations had 30 days to intervene. The undertakings concerned can respond to observations and amend their proposals until 27 February 2015. However, those commitments must be evaluated by 29 March 2015. Following a complaint submitted by the Regional Central Purchasing Agency of the Italian Region of Lombardia, in January 2014, AGCM opened an

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Author

  • DG COMP (Brussels)

Quotation

Andrea Usai, The Italian Competition Authority decides that commitments submitted by pharmaceutical companies in order to alleviate competition concerns should have been published (Arca / Novartis-Italfarmaco), 19 December 2014, e-Competitions Bulletin Commitment Decisions, Art. N° 71307

Visites 150

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues